Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Sumatriptan on Levcromakalim-Induced Migraine
NCT05211050Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- Mar 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of sumatriptan in migraine without aura (2 arms), sponsored by Dansk Hovedpinecenter. Primary endpoint: Incidence of migraine attacks. Started Mar 2022; status: completed.
02
Drugs
sumatriptan
03
Conditions
migraine without aura
Beyond the preview
Go deeper on NCT05211050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05211050.